ABINGDON HEALTH PLC Logo

ABINGDON HEALTH PLC

A CDMO specializing in lateral flow assays, offering development to manufacturing services.

ABDX | IL

Overview

Corporate Details

ISIN(s):
GB00BLB79S77 (+2 more)
LEI:
213800XFI4WV3FBILO20
Country:
United Kingdom
Address:
YORK BIOTECH CAMPUS, YO41 1LZ YORK

Description

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 15:00
Result of Annual General Meeting
English 14.5 KB
2025-12-04 08:45
Vesting and Award of Options under LTIP
English 87.4 KB
2025-12-02 16:20
Holding(s) in Company
English 119.0 KB
2025-11-14 15:10
Notice of AGM & Publication of 2025 Annual Report
English 15.7 KB
2025-11-11 08:20
Final Results
English 305.0 KB
2025-11-10 08:10
c.US$2m multiplex diagnostic test contract win
English 17.6 KB
2025-11-06 08:30
Launch of seaweed-based lateral flow housings
English 22.3 KB
2025-11-04 18:10
Holding(s) in Company
English 50.5 KB
2025-11-04 08:25
Holding(s) in Company
English 52.1 KB
2025-11-03 08:30
Notice of Results
English 17.3 KB
2025-10-30 10:43
Result of Meeting and TVR
English 61.1 KB
2025-10-17 08:00
Result of Retail Offer
English 24.5 KB
2025-10-14 08:58
Launch of Retail Offer
English 50.1 KB
2025-10-14 08:47
Result of Placing and Notice of GM
English 30.1 KB
2025-10-13 18:04
Proposed Placing and Retail Offer
English 214.5 KB

Automate Your Workflow. Get a real-time feed of all ABINGDON HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABINGDON HEALTH PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ABINGDON HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.